• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Saudi Arabia·Healthcare·4013.SR
Share

Dr. Sulaiman Al Habib Medical Services Group Company Stocks

SAR 231.6Last Updated 27.07.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

SAR 20.06B

SAR 231.6
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Headquartered in Riyadh, Saudi Arabia, Dr. Sulaiman Al Habib Medical Services Group Company, established in 1993, specializes in the development, management, and operation of a wide spectrum of healthcare facilities across the Kingdom. Its extensive portfolio encompasses general and specialized hospitals, various medical complexes, outpatient surgical centers, and pharmaceutical facilities. The group operates hospitals focusing on specific areas such as maternity services, orthopedics, and spinal surgeries. Furthermore, it oversees specialized clinics for dermatology, plastic surgery, ophthalmology, obesity treatment, and fertility, complemented by its network of pharmacies. Beyond direct patient care, the company provides home medical services, advanced laboratory diagnostics, technology and information system support, facility upkeep, medical equipment maintenance, and telemedicine solutions.

Company Valuation

Overvalued
2/7

Based on key historical and expected multiples, the stock is overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA, rea

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of 4013.SR is 265 and suggests 23.1% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

29.07.2026 12:40

Oninvest Index: Space-Sector Small-Cap Stocks Have Lost Their Half-Year Gains. What's Next?

29.07.2026 12:08

Russia has issued an arrest warrant for Telegram founder Durov under a terrorism-related charge

29.07.2026 11:27

OpenAI Models Have Hacked a Second Company: What Will the Consequences Be?

29.07.2026 10:49

Top Stories This Morning: Oil Prices Spike, SK Hynix Shares Plunge, ChatGPT Hits 1 Billion Users

29.07.2026 08:00

Europe's richest man regrets selling his Netflix and Google shares too early

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026